RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Ex Vivo Surface Decoration of Phenylboronic Acid onto Natural Killer Cells for Sialic Acid-Mediated Versatile Cancer Cell Targeting.
Ex Vivo Surface Decoration of Phenylboronic Acid onto Natural Killer Cells for Sialic Acid-Mediated Versatile Cancer Cell Targeting.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
苯硼酸(PBA)在唾液酸过表达的癌细胞中被高度认为是一种重要的癌症识别基团。在本研究中,脂质介导的生物材料将PBA分子整合到自然杀伤(NK)细胞表面,以构建受体介导的免疫细胞治疗模块。
因此,合成了1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺(DSPE)脂质偶联的二-PEG-PBA(DSPE PEG -di(PEG-PBA))生物材料。DSPE PEG -di(PEG-PBA)生物材料对唾液酸(SA)表现出高亲和力,并通过pH 6.5和7.4下的荧光光谱得到证实。DSPE PEG -di(PEG-PBA)成功锚定在NK细胞表面(PBA-NK),该生物材料保持了固有特性,如活力、配体可用性(FasL和TRAIL)以及对LPS的细胞因子分泌反应。PBA-NK细胞的抗癌功效针对2D癌细胞(MDA-MB-231、HepG2和HCT-116)以及MDA-MB-231细胞的3D肿瘤球体进行了评估。PBA-NK细胞对SA过表达的癌细胞表现出显著增强的抗癌效果。
因此,PBA-NK细胞代表了一种用于癌症免疫治疗的新抗癌策略。
Phenylboronic acid (PBA) has been highly acknowledged as a significant cancer recognition moiety in sialic acid-overexpressing cancer cells. In this investigation, lipid-mediated biomaterial integrated PBA molecules onto the surface of natural killer (NK) cells to make a receptor-mediated immune cell therapeutic module.
Therefore, a 1,2-distearoyl- sn -glycero-3-phosphorylethanolamine (DSPE) lipid-conjugated di-PEG-PBA (DSPE PEG -di(PEG-PBA) biomaterial was synthesized. The DSPE PEG -di(PEG-PBA) biomaterial exhibited a high affinity for sialic acid (SA), confirmed by fluorescence spectroscopy at pH 6. 5 and 7. 4.
DSPE PEG -di(PEG-PBA) was successfully anchored onto NK cell surfaces (PBA-NK), and this biomaterial maintains intrinsic properties such as viability, ligand availability (FasL & TRAIL), and cytokine secretion response to LPS. The anticancer efficacy of PBA-NK cells was evaluated against 2D cancer cells (MDA-MB-231, HepG2, and HCT-116) and 3D tumor spheroids of MDA-MB-231 cells. PBA-NK cells exhibited greatly enhanced anticancer effects against SA-overexpressing cancer cells.
Thus, PBA-NK cells represent a new anticancer strategy for cancer immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。